Zai Lab (ZLAB) EBITDA Margin Growth (5y) (2024 - 2026)

Zai Lab (ZLAB) EBITDA Margin Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 38,987.00
Mar 31, 2026 105,999.00
Dec 31, 2025 57,669.00
Sep 30, 2025 47,844.00
Jun 30, 2025 71,376.00
Mar 31, 2025 51,078.00
Dec 31, 2024 105,824.00
Sep 30, 2024 126,030.00